Status:
COMPLETED
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors
Lead Sponsor:
Fred Hutchinson Cancer Center
Collaborating Sponsors:
Livestrong Foundation
National Cancer Institute (NCI)
Conditions:
Breast Carcinoma
Cancer Survivor
Eligibility:
All Genders
18-39 years
Phase:
NA
Brief Summary
This randomized clinical trial studies survivorship care in reducing symptoms in young adult cancer survivors. Survivorship care programs that identify the needs of young adult cancer survivors and wa...
Detailed Description
PRIMARY OBJECTIVES: I. To test the impact of providing the essential elements of survivorship care on survivorship outcomes as indicated by reduction in symptoms (pain, fatigue, sleep disturbance, de...
Eligibility Criteria
Inclusion
- Patients enrolled on phase 1 of the study are eligible (and/or if recruited from tumor registry or clinic follow-up schedules)
- Diagnosed with invasive malignancy including: breast, gastrointestinal track, female or male genitourinary system, sarcoma of bone or soft-tissue, leukemia and lymphoma
- Treated at one of the Survivorship Centers of Excellence or their community affiliates
- Received a therapeutic intervention with at least one of the following modalities: surgery, cytotoxic chemotherapy, biological or targeted agents, radiation therapy (any modality)
- Currently between 1.0 and 4.99 years from the completion of active cancer-directed therapy (cytotoxic chemotherapy, radiation therapy and/or definitive surgical intervention)
- Patient must still be in active follow-up: seen for a follow-up visit in the participating center at least once in the 3 years prior to enrollment and/or scheduled to be seen for follow-up in the next 6 months (i.e. in active follow-up)
- May be receiving "maintenance" therapy that has a goal of prevention of recurrence but there should be no expectations for further active treatment
- Able to read and speak English adequate to complete the patient-reported outcomes (PRO) assessment
Exclusion
- Prior visit to a survivorship clinic or previously provided with a treatment summary and care plan
Key Trial Info
Start Date :
August 3 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
390 Patients enrolled
Trial Details
Trial ID
NCT02192333
Start Date
August 3 2015
End Date
December 31 2019
Last Update
October 9 2020
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States, 90095
2
University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States, 80045
3
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
4
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States, 27599